Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Net revenue	$ 1,116,898	$ 864,500	$ 3,100,936	$ 2,663,390
Cost of sales (exclusive of amortization shown separately below)	490,824	362,321	1,340,660	1,128,314
Amortization of acquired intangible assets	8,322	10,982	22,001	33,271
Total cost of sales	499,146	373,303	1,362,661	1,161,585
Gross profit	617,752	491,197	1,738,275	1,501,805
Operating Expenses
Selling, general, and administrative	228,457	182,401	633,317	544,483
Research and development	76,436	66,801	209,498	189,258
Amortization of acquired intangible assets	12,188	7,730	29,701	23,175
Acquisition related expenses	0	0	9,157	0
Total operating expenses	317,081	256,932	881,673	756,916
Income from operations	300,671	234,265	856,602	744,889
Other income (loss), net:
Interest (expense) income, net	(14,964)	(5,462)	(32,436)	(16,770)
Loss attributable to equity method investments (note 5)	(183)	(2,627)	(5,037)	(5,927)
Gain (loss) on equity investments (note 5)	6,418	(1,735)	11,506	(527)
Other, net	(2,564)	1,878	(5,773)	729
Total other income (loss), net	(11,293)	(7,946)	(31,740)	(22,495)
Income before income taxes	289,378	226,319	824,862	722,394
Income taxes	56,878	47,307	156,970	138,018
Net income	$ 232,500	$ 179,012	$ 667,892	$ 584,376
Basic earnings per share (dollars per share)	$ 1.58	$ 1.22	$ 4.55	$ 4.00
Diluted earnings per share (dollars per share)	1.58	1.22	4.53	3.97
Dividend declared per share (dollars per share)	$ 0.44	$ 0.42	$ 1.32	$ 1.26
Basic shares outstanding (000's) (shares)	146,914	146,240	146,681	145,969
Diluted shares outstanding (000's) (shares)	147,395	146,962	147,400	147,034
Total Sleep and Respiratory Care
Net revenue	$ 980,116	$ 763,358	$ 2,741,541	$ 2,365,697
Cost of sales (exclusive of amortization shown separately below)	443,925	324,618	1,214,072	1,017,494
Amortization of acquired intangible assets	1,367	1,071	3,939	3,043
Software as a Service
Net revenue	136,782	101,142	359,395	297,693
Cost of sales (exclusive of amortization shown separately below)	46,899	37,703	126,588	110,820
Amortization of acquired intangible assets	$ 6,955	$ 9,911	$ 18,062	$ 30,228